Skip to main content
Clinical Trials/NCT05016258
NCT05016258
Recruiting
N/A

Multicenter Observational Study on Performance and Safety Use of "KONTACT MB" Dental Implant in Daily Practice

Biotech Dental1 site in 1 country159 target enrollmentJanuary 26, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dentistry
Sponsor
Biotech Dental
Enrollment
159
Locations
1
Primary Endpoint
Peri implant bone level
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

A multicenter prospective observational study aims to illustrate the clinical outcome of dental implants "Kontact MB" and the effects of its Mono Block design on the peri implant bone tissue recession and soft tissue conservation.

All the enrolled patients will be eligible for one or multiple implant-supported fixed restoration(s) according to the routine clinical practice and the manufacturer's instruction for use.

Registry
clinicaltrials.gov
Start Date
January 26, 2022
End Date
October 2025
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Edentulous patient (partially or completely AND formerly, recently or just before implantation) requiring the placement of one (or more) dental implant (s) in maxillary or mandibular
  • Age ≥ 18 years
  • Good general health (ASA score between \[1-2\])
  • Sufficient bone volume and quality (with or without bone graft) to support the implant
  • Given a writing consent for the collection of his medical data as part of the study (delivery of a patient's sheet)

Exclusion Criteria

  • Poor oral hygiene
  • Bruxism, parafunctional habits, occlusion disorders and / or temporomandibular joints
  • Infections and oral inflammation such as periodontitis, gingivitis
  • Patient with metabolic disorders (eg diabetes mellitus) or bone disease that may compromise peri-implant tissue healing
  • Heavy smoker (\> 10 cigarettes / day)
  • Patient with a pathology or immunosuppressive therapy such as chemotherapy, radiotherapy
  • Patient on prolonged steroid therapy
  • Titanium / titanium alloy allergy
  • Alcohol or drug abuse
  • Pregnant woman (or likely to be pregnant); or breastfeeding

Outcomes

Primary Outcomes

Peri implant bone level

Time Frame: up to 36 months

Bone level evolution compare to the bone level at implantation day

Keratinized tissues level

Time Frame: up to 36 months

Assessment of keratinized tissues

Gingival index

Time Frame: up to 36 months

Gingival index assess with Loë and Silness Score

Implant survival rate

Time Frame: up to 36 months

Number of implants still in function up to 36 months post implantation

Bleeding index

Time Frame: up to 36 months

Bleeding index on probing following the Mombelli score

Study Sites (1)

Loading locations...

Similar Trials